Automate Your Wheel Strategy on ZTS
With Tiblio's Option Bot, you can configure your own wheel strategy including ZTS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ZTS
- Rev/Share 21.0851
- Book/Share 11.1818
- PB 13.6222
- Debt/Equity 1.3645
- CurrentRatio 1.7597
- ROIC 0.2232
- MktCap 67505634560.0
- FreeCF/Share 4.9854
- PFCF 30.4216
- PE 25.9562
- Debt/Assets 0.469
- DivYield 0.0127
- ROE 0.5321
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ZTS | Leerink Partners | Outperform | Market Perform | -- | $155 | July 17, 2025 |
| Downgrade | ZTS | Stifel | Buy | Hold | -- | $160 | June 18, 2025 |
News
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
2 Stocks to Buy With $5,000 and Hold for a Decade
Published: August 10, 2025 by: The Motley Fool
Sentiment: Positive
It can be tempting to try to predict market movements so you buy low and sell high, but it's notoriously difficult to execute successfully. Even if you succeed once or twice, replicating that often enough to build a profitable portfolio that stands the test of time is next to impossible.
Read More
Top 50 High-Quality Dividend Stocks For August 2025
Published: August 06, 2025 by: Seeking Alpha
Sentiment: Positive
My investable universe of 50 high-quality dividend growth stocks aims to identify attractive opportunities based on valuation and future return potential. Currently, 20 stocks offer an estimated future return of at least 10%, with 10 of these also appearing potentially undervalued by my Free Cash Flow model. Top highlighted stocks like MKTX, RACE, RMD, MSCI, and TTC combine strong free cash flow growth, attractive valuations, and double-digit return estimates.
Read More
Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.
Read More
Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript
Published: August 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Zoetis Inc. (NYSE:ZTS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Kristin C. Peck - CEO & Director Steven Frank - Vice President of Investor Relations Wetteny N.
Read More
Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
ZTS eyes an earnings beat as companion animal drugs like Simparica Trio and Apoquel are expected to drive Q2 revenue gains.
Read More
Countdown to Zoetis (ZTS) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Zoetis (ZTS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read More
USNA or ZTS: Which Is the Better Value Stock Right Now?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Why Zoetis (ZTS) Could Beat Earnings Estimates Again
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)
Published: July 18, 2025 by: Seeking Alpha
Sentiment: Positive
Zoetis Inc. is the dominant animal health company, growing market share, revenue, and margins, now trading at a multi-year low valuation. Fundamentals remain strong: rising EPS, aggressive buybacks, and a shareholder yield of 3.2% with robust secular tailwinds supporting long-term growth. Key franchises (Simparica, Apoquel, Librela) are expanding, protected by patents, into the 2030s-2040s, with further growth potential from under-penetrated markets.
Read More
Here's Why Zoetis (ZTS) is a Strong Growth Stock
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Should You Invest in Zoetis (ZTS) Based on Bullish Wall Street Views?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
SGIOY or ZTS: Which Is the Better Value Stock Right Now?
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS).
Read More
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded.
Published: June 18, 2025 by: Barrons
Sentiment: Negative
The Merck rival faces intense competition that could limit multiple expansion, Stifel analysts say.
Read More
Top Stock Movers Now: Jabil, Oracle, Zoetis, and More
Published: June 18, 2025 by: Investopedia
Sentiment: Positive
U.S. equities were higher at midday as President Donald Trump again called on Federal Reserve Chair Jerome Powell to cut interest rates ahead of today's Fed decision. The Dow Jones Industrial Average, S&P 500, and Nasdaq all gained.
Read More
Here's Why Zoetis (ZTS) is a Strong Momentum Stock
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Zoetis Stock Rises 13% in a Month: Time to Add to Your Portfolio?
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Positive
ZTS jumps 13% in a month as strong new product sales, strategic deals, and rising earnings estimates boost investor confidence.
Read More
Why Is Zoetis (ZTS) Up 8.1% Since Last Earnings Report?
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock?
Read More
DSNKY vs. ZTS: Which Stock Is the Better Value Option?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Drugs stocks have likely encountered both Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) and Zoetis (ZTS).
Read More
The “English Warren Buffett” Dumped Most of His Portfolio, But Bought Big Into These 3 Stocks
Published: June 04, 2025 by: 24/7 Wall Street
Sentiment: Positive
His concentrated portfolio strategy, focusing on high-quality, long-term holdings, reflects a disciplined, tech-heavy investment approach.
Read More
Zoetis Inc. (ZTS) William Blair 45th Annual Growth Stock Conference (Transcript)
Published: June 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Zoetis Inc. (NYSE:ZTS ) William Blair 45th Annual Growth Stock Conference June 3, 2025 11:40 AM ET Company Participants Wetteny Joseph - CFO Conference Call Participants Brandon Vazquez - William Blair Brandon Vazquez Right. Good morning, everyone.
Read More
Top 15 High-Growth Dividend Stocks For June 2025
Published: June 02, 2025 by: Seeking Alpha
Sentiment: Positive
My Top 15 High-Growth Dividend Stocks outperformed SPY and VIG in May, gaining 6.45% versus SPY's 6.28% and VIG's 3.61%. The list's year-to-date return is 6.07%, beating SPY every month in 2025, though still short of my 12% annualized target. The June 2025 Top 15 stocks offer a 1.34% average dividend yield with a 22.82% 5-year dividend growth rate and are 25% undervalued.
Read More
Why Zoetis (ZTS) is a Top Momentum Stock for the Long-Term
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Zoetis Inc. (ZTS) Stifel 2025 Jaws & Paws Conference (Transcript)
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Neutral
Zoetis Inc. (NYSE:ZTS ) Stifel 2025 Jaws & Paws Conference May 29, 2025 9:10 AM ET Company Participants Wetteny Joseph - Chief Financial Officer Conference Call Participants Jon Block - Stifel Jon Block Great. Thank you.
Read More
Dr. Mark Stetter Elected to Zoetis Board of Directors
Published: May 22, 2025 by: Business Wire
Sentiment: Neutral
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced the election of Dr. Mark Stetter to its Board of Directors, effective as of the company's annual shareholder meeting on May 21, 2025. Dr. Stetter brings extensive experience in veterinary medicine and animal health, including as Dean of the University of California, Davis School of Veterinary Medicine, to the Zoetis Board. His career in animal health includes pets, livestock, exotic animals, research and wildlife. He wil.
Read More
Zoetis (ZTS) Upgraded to Buy: Here's Why
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Zoetis (ZTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Wall Street Analysts Think Zoetis (ZTS) Could Surge 26.18%: Read This Before Placing a Bet
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Zoetis (ZTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
About Zoetis Inc. (ZTS)
- IPO Date 2013-02-01
- Website https://www.zoetis.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Kristin C. Peck
- Employees 13800